Cannabics Pharmaceuticals Shows Specific Cultivars Identified to Have Positive Anti-Tumor Effects on Gastric Adenocarcinoma

On March 11, 2020 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, reported that it has completed a scan of selected RCKMC’s cannabis strains. Results obtained have shown that two specific strains have demonstrated higher anti-tumor activity (Press release, Cannabics Pharmaceuticals, MAR 11, 2020, View Source [SID1234555438]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cells monitored for 48h using fluorescent microscopy. AGS cells were treated with Extract of CNBX-RCK cannabis plant 802-2. Cells were stained with nuclear dye (blue) and cell death (yellow).
Cells monitored for 48h using fluorescent microscopy. AGS cells were treated with Extract of CNBX-RCK cannabis plant 802-2. Cells were stained with nuclear dye (blue) and cell death (yellow).
The strains were examined at the company’s High Throughput Screening (HTS) facility located in Israel, in which their anti-tumor properties were examined on a wide range of cancers. Analysis of the scans revealed specific cultivars which have a more significant necrotic effect on Gastric Adenocarcinoma cells.

The results will be used to further breed the selected cultivars for specific cancers, focusing on Gastric cancers. The cultivars to be developed will be the source for active pharmaceutical ingredients (API’s) for future clinical studies.

About RCKMC

RCK is an Israeli cannabis company, breeding tailor-made medical strains and repeatable & stable cannabis hybrid-seeds, being the first company to operate a methodological marker-assisted-breeding of cannabis, having cutting-edge proprietary technologies and led by professional team, RCKMC opens the gate to a new era of cannabis agriculture.